This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Intern Med. 1970;126(4):569-580.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Chondroitin therapy

Administration of chondroitin sulfate A appears to be effective in preventing heart attacks, according to Lester Morrison, MD, professor and director of the Institute for Arteriosclerosis Research at Loma Linda University School of Medicine.

Dr. Morrison reported to the recent American College of Angiology meeting in New York on the results of a double-blind study of 120 patients with a history of myocardial infarction and/or coronary artery disease verified by electrocardiography.

Half the patients received chondroitin sulfate A (CSA) in addition to conventional therapy. CSA is a mucopolysaccharide compound.

His results were quite dramatic: six "coronary incidents" and five related deaths in the experimental group compared to 36 "coronary incidents" and nine related deaths among the 60 matched control patients.

Dr. Morrison added that experimental studies have shown CSA can prevent as well as accelerate regression and healing of coronary and aortic atherosclerosis.

The patients had been treated . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?